Navigation Links
Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009

Executive Chairman to Discuss Alternative Approach to Biofuel and Chemical Production

(PRWEB) November 13, 2009 -- Glycos Biotechnologies, Inc. (GlycosBio), a metabolic engineering innovator in biologically converting non-sugar feedstocks into next generation bioproducts, today announced Rich Cilento, Executive Chairman, will be a presenter at Alternative Energy Innovations 2009 on November 17th in Redwood City, CA.

With a mission to find a better way to create biofuels and chemicals, GlycosBio has uniquely discovered a number of microorganisms that can biologically convert by-products including glycerol and free fatty acids into higher-value green chemicals. By not following the typical sugars-based fermentation research, GlycosBio has created a proprietary technology that provides the industry with an alternative approach to traditional corn or sugar-based biofuel and chemical production.

In his presentation, Cilento will discuss the industry’s need to integrate microbe and fermentation technologies into their manufacturing plans. He will provide an overview of GlycosBio’s technology and how biofuel, oleochemical, palm oil and petrochemical producers can protect themselves from the commodity risk that a single feedstock business model brings; rapidly implement a biorefinery based on their existing plant and equipment; create greater yields and increase product values.

What:    “GlycosBio Business and Technology Overview”

Who:   Rich Cilento, Executive Chairman, GlycosBio

Where:   Alternative Energy Innovations: Sofitel San Francisco Bay, Redwood City, CA

When:   Biofuels Track: Tuesday, November 17 - 11:25am and 12:10pm

About Rich Cilento
Rich Cilento has extensive leadership and technical experience with energy, biotechnology, and information technology companies. He received national business honors in 2006, winning the Ernst and Young Entrepreneur of the Year Award for Energy Technology. Cilento is currently serving as Executive Chairman of DFJ Mercury portfolio company GlycosBio. Previously, he was the Founder, President and CEO of FuelQuest, Inc. (acquired by Saracen Energy), a provider of on-demand supply chain management and tax automation software and services for suppliers, distributors, fuel buyers and traders in Global Downstream Energy.

Cilento began his career at NASA where he was a space shuttle flight controller. He and his flight control team had responsibility for redesigning NASA’s Mission Control Center and implementing NASA’s Software Management Plan.

Cilento holds a BS in Aeronautical and Astronomical Engineering from the University of Illinois, an MBA from the University of Houston and serves as an advisor to a number of small businesses in Texas.

About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By creating differentiated bioprocesses, GlycosBio’s bioconversion technology can lower costs, provide a non food energy balance and price stability to the chemical and biofuel industries. GlycosBio is a Houston-based industrial biotechnology company started with technology initially developed at Rice University. For more information, visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
3. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
4. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
5. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
6. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
7. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
8. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
9. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
10. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
11. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International ... and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. ... 2015, where ISPE hosted the largest number of attendees in more than a ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... This fall, ... at competitive events in five states to develop and pitch their BIG ideas to ... from each state are competing for votes to win the title of SAP's Teen ...
(Date:11/24/2015)... Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that ... 2015 at 11:00 a.m. Israel time, at the ... Yigal Allon Street, 36 th Floor, Tel Aviv, Israel ... Paneth and Izhak Tamir to the Board of Directors; ... external directors; , approval of an amendment to certain terms of ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment ... Chief Operating Officer. , Having joined InSphero in November 2013 as Business ... to Head of InSphero Diagnostics in 2014. There she has built up the ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):